| Literature DB >> 31354400 |
Petra Iris Baeumler1, Peter Conzen2, Dominik Irnich1.
Abstract
Objectives: This prospective cohort study explored whether two distinguished sensory parameters predicted acupuncture effects in chronic pain patients; namely high temporal summation of pain (TS) indicating spinal synaptic facilitation as well as a low vibration detection threshold (VDT) indicating a loss of Aβ-fiber function.Entities:
Keywords: quantitative sensory testing; responder; sensitization; vibration detection threshold; wind-up ratio
Year: 2019 PMID: 31354400 PMCID: PMC6637793 DOI: 10.3389/fnins.2019.00498
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Figure 1Study flow-chart. MOCAM, Munich Outpatient Program in Complementary and Alternative Medicine; VDT, vibration detection threshold; WUR, wind-up ratio; CS, control site; PS, pain site.
Patient characteristics (n = 100).
| Age [a], mdn (IQR) | 50 (43–56) | Persistent pain with somatic and mental factors | F45.41 | 77 | |
| Female/male, | 83/17 | Migraine and other headache syndromes | G43.-/ G44.- | 21 | |
| Right handed, | 98 | Disorders of trigeminal nerve | G50.- | 4 | |
| Pain duration [m], mdn (IQR) | 66 (22–187) | Mononeuropathies of upper limb | G56.- | 2 | |
| Pain intensity | Maximum | 80 (61–90) | Tinnitus | H93.1 | 1 |
| Average | 50 (40–60) | Disorders of circulatory system | I73.9/ I80.28 | 2 | |
| Current | 45 (30–60) | Temporomandibular joint disorders | K07.6 | 5 | |
| Chronicity | 1 | 7 | Arthropathies | M00-25 | 18 |
| MPSS, | 2 | 38 | Polymyalgia rheumatica | M35.3 | 1 |
| 3 | 55 | Deforming dorsopathies | M40–43 | 3 | |
| Previous surgery because of chronic pain, | 29 | Spondylopathies | M45–49 | 2 | |
| Main pain area, | Lower back | 25 | Other dorsopathies | M50-54 | 37 |
| Neck/cervical-spine area | 22 | Shoulder lesions | M75.- | 7 | |
| Thoracic spine-area | 8 | Enthesopathies of lower limb, excluding foot | M76.- | 5 | |
| Headache | 9 | Other enthesopathies | M77.- | 5 | |
| Jaw | 7 | Myalgia, myofascial pain syndromes | M79.1- | 64 | |
| Shoulder/arm | 10 | Pain in limb | M79.6- | 1 | |
| Hip | 5 | Fibromyalgia | M79.70 | 8 | |
| Knee, lower extremity | 6 | Osteoporosis without pathological fracture | M81.- | 2 | |
| Foot | 6 | Osteomyelitis | M86.- | 1 | |
| Abdomen | 2 | Other biomechanical lesions | M99.8- | 7 | |
| Pain medication, | Non-opioid analgesics (NSAID/ | 68 | Other congenital deformities of feet | Q66.8 | 1 |
| Pyrazolone/Paracetamole) | Symptoms and signs abdomen/urinary system | R10.1/ R39.8 | 2 | ||
| Weak opioids | 12 | Pain, unspecified | R52.9 | 1 | |
| Antidepressants | 23 | Fracture of thoracic vertebra | S22.0 | 1 | |
| Anticonvulsants | 9 | Presence of other functional implants | Z96.- | 2 | |
| Triptans | 6 | Mental and behavioral disorders due to | F10 - F19 | 7 | |
| Muscle relaxants | 2 | psychoactive substance use | |||
| Disease-modifying | 1 | Mood [affective] disorders | F30 - F39 | 34 | |
| antirheumatic drugs | Neurotic, stress-related and somatoform disorders | F40 - F48 | 22 | ||
| Phytopharmaceuticals | 4 | Behavioral syndromes associated with | F50 - F59 | 12 | |
| No analgesics | 15 | physiological disturbances and physical factors | |||
n, absolute frequency corresponding to relative frequencies since the total number of patients was 100; a, years; m, months; mdn, median; IQR, interquartile range; VRS, verbal rating scale; MPSS, Mainz Pain Staging System; ICD-10, 10th revision of the International Statistical Classification of Diseases and Related Health Problems.
TS and VDT in patients with and without acupuncture effect.
| VDT CS | 38 | 56 | 25 | 69 | |||
| (x/8) | mdn [IQR] | 7.8 [7.5–8.0] | 8 [7.5–8.0] | 0.346 | 7.8 [7.5–8.0] | 8.0 (7.5–8.0) | 0.61 |
| VDT PS | 38 | 56 | 25 | 69 | |||
| (x/8) | mdn [IQR] | 5.9 [4.3–6.7] | 5.3 [3.9–6.3] | 0.135 | 5.7 [4.3–6.7] | 5.3 (4.0–6.4) | 0.353 |
| WUR CS | n | 38 | 55 | 25 | 68 | ||
| (VRS-ratio) | mdn [IQR] | 2.4 [1.4–3.4] | 1.7 [1.3–2.8] | 0.189 | 2.3 [1.4–3.4] | 1.7 (1.3–3.0) | 0.553 |
| WUR PS | 37 | 53 | 25 | 65 | |||
| (VRS-ratio) | mdn [IQR] | 2.0 [1.6–4.0] | 1.8 [1.5–3.0] | 0.124 | 2.0 [1.6–3.2] | 1.9 (1.5–3.1) | 0.479 |
| VDT CS | n | 37 | 59 | 24 | 72 | ||
| (x/8) | mdn [IQR] | 8.0 [7.6–8.0] | 8.0 [7.5–8.0] | 0.452 | 8.0 [7.7–8.0] | 8.0 (7.5–8.0) | 0.345 |
| VDT PS | 37 | 59 | 24 | 72 | |||
| (x/8) | mdn [IQR] | 5.7 [4.6–6.7] | 5.3 [4.0–6.5] | 0.265 | 5.7 [4.4–7.0] | 5.3 (4.2–6.5) | 0.367 |
| WUR CS | 36 | 59 | 23 | 72 | |||
| (VRS-ratio) | mdn [IQR] | 2.4 [1.5–3.6] | 1.6 [1.3–2.8] | 0.050 | 2.5 [1.6–4.4] | 1.6 (1.3–2.9) | 0.029 |
| WUR PS | 36 | 56 | 23 | 69 | |||
| (VRS-ratio) | mdn [IQR] | 2.3 [1.6–3.3] | 1.9 [1.5–2.6] | 0.13 | 2.8 [1.6–3.4] | 1.9 (1.5–2.7) | 0.085 |
| VDT CS | 52 | 43 | 17 | 78 | |||
| (x/8) | mdn [IQR] | 8.0 [7.5–8.0] | 8.0 [7.7–8.0] | 0.373 | 8.0 [7.4–8.0] | 8.0 (7.5–8.0) | 0.953 |
| VDT PS | 52 | 43 | 17 | 78 | |||
| (x/8) | mdn [IQR] | 5.5 [4.0–6.6] | 5.7 [4.5–6.7] | 0.381 | 4.7 [4.0–6.3] | 5.7 (4.3–6.7) | 0.319 |
| WUR CS | 51 | 43 | 16 | 78 | |||
| (VRS-ratio) | mdn [IQR] | 1.7 [1.3–3.0] | 2.0 [1.3–2.8] | 0.381 | 1.7 [1.6–3.0] | 1.9 (1.3–3.0) | 0.856 |
| WUR PS | 50 | 42 | 17 | 75 | |||
| (VRS-ratio) | mdn [IQR] | 2.0 [1.5–2.8] | 2.0 [1.4–3.2] | 0.931 | 2.0 [1.5–2.7] | 2.0 (1.5–3.1) | 0.629 |
| VDT CS | 75 | 18 | |||||
| (x/8) | mdn [IQR] | 8.0 [7.5–8.0] | 8.0 [7.6–8.0] | 0.901 | |||
| VDT PS | 75 | 18 | |||||
| (x/8) | mdn [IQR] | 5.7 [4.2–6.7] | 5.3 [4.0–6.6] | 0.942 | |||
| WUR CS | n | 74 | 18 | ||||
| (VRS - ratio) | mdn [IQR] | 1.7 [1.3–3.0] | 2.2 [1.4–3.1] | 0.598 | |||
| WUR PS | 71 | 18 | |||||
| (VRS-ratio) | mdn [IQR] | 2.0 [1.5–3.0] | 2.3 [1.5–3.4] | 0.314 | |||
Resp30/50, Acupuncture responders defined according to a reduction in pain intensity after the first acupuncture treatment of at least 30 and 50%, respectively; VDT, vibration detection threshold; x/8, score out of eight on the Rydel-Seiffer tuning fork; WUR, wind-up ratio; VRS-ratio, ratio of the pain intensities evoked by one and by ten pin-prick stimuli of 256 mN as evaluated by the verbal rating scale (0–100); CS, control site; PS, pain site; n, case number; mdn, median; IQR, interquartile range;
statistically significant at an α-error of 5% according to Mann-Whitney-U test.
Figure 2Scatterplot of percent change in pain intensity after the first acupuncture treatment against WUR and VDT at the PS and CS. Percent change in pain intensity as evaluated by the verbal rating scale (VRS) was calculated as (VRSpost – VRSpre)/VRSpre *100. Accordingly, negative values represent a pain relief. The reference line indicates a 30% reduction in pain intensity as the cut-off for clinically relevant pain relief. WUR, wind-up ratio [ratio of the pain intensities evoked by one and by 10 pin-prick stimuli of 256 mN as evaluated by the verbal rating scale (0–100)]; VDT, vibration detection threshold; CS, control site; PS, pain site; filled points, (A,B) subjects with high TS (WUR > 2.5 VRS-ratio) as identified by the 66%-percentile (C) low VDT at the CS ( ≤ 7.7/8) (D) low VDT at the PS ( ≤ 4.3/8) as identified by the 33%- percentile; empty points, subjects with low TS or high VDT, respectively.
Crude association between acupuncture effects and high TS and low VDT.
| VDT control site (x/8) | >7.7 | 21 | 39 | ref | 15 | 45 | ref | ||
| ≤ 7.7 | 17 | 17 | 1.9 [0.8–4.4] | 0.191 | 10 | 24 | 1.3 [0.5–3.2] | 0.637 | |
| VDT pain site (x/8) | >4.3 | 28 | 35 | ref | 18 | 45 | ref | ||
| ≤ 4.3 | 10 | 21 | 0.6 [0.2–1.5] | 0.275 | 7 | 24 | 0.7 [0.3–2.0] | 0.625 | |
| WUR control site (VRS-ratio) | ≤ 2.5 | 20 | 41 | ref | 14 | 47 | ref | ||
| >2.5 | 18 | 14 | 2.6 [1.1–6.4] | 0.045 | 11 | 21 | 1.8 [0.7–4.5] | 0.325 | |
| WUR pain site (VRS-ratio) | ≤ 2.5 | 21 | 36 | ref | 16 | 41 | ref | ||
| >2.5 | 16 | 17 | 1.6 [0.7–3.8] | 0.374 | 9 | 24 | 1.0 [0.4–2.5] | 1.000 | |
| VDT control site (x/8) | >7.7 | 24 | 38 | ref | 17 | 45 | ref | ||
| ≤ 7.7 | 13 | 21 | 1.0 [0.4–2.3] | 1.000 | 7 | 27 | 0.7 [0.3–1.9] | 0.623 | |
| VDT pain site (x/8) | >4.3 | 29 | 37 | ref | 18 | 48 | ref | ||
| ≤ 4.3 | 8 | 22 | 0.5 [0.2–1.2] | 0.120 | 6 | 24 | 0.7 [0.2–1.9] | 0.612 | |
| WUR control site (VRS-ratio) | ≤ 2.5 | 19 | 44 | ref | 11 | 52 | ref | ||
| >2.5 | 17 | 15 | 2.6 [1.1–6.3] | 0.043 | 12 | 20 | 2.8 [1.1–7.5] | 0.043 | |
| WUR pain site (VRS-ratio) | ≤ 2.5 | 19 | 41 | ref | 10 | 50 | ref | ||
| >2.5 | 17 | 15 | 2.4 [1.0–5.9] | 0.072 | 13 | 19 | 3.4 [1.3–9.1] | 0.021 | |
| VDT control site (x/8) | >7.7 | 32 | 30 | ref | 11 | 51 | ref | ||
| ≤ 7.7 | 20 | 13 | 1.4 [0.6–3.4] | 0.517 | 6 | 27 | 1.0 [0.3–3.1] | 1.000 | |
| VDT pain site (x/8) | >4.3 | 32 | 33 | ref | 9 | 56 | ref | ||
| ≤ 4.3 | 20 | 10 | 2.1 [0.8–5.1] | 0.127 | 8 | 22 | 2.3 [0.8–6.6] | 0.155 | |
| WUR control site (VRS-ratio) | ≤ 2.5 | 32 | 30 | ref | 10 | 52 | ref | ||
| >2.5 | 19 | 13 | 1.4 [0.6–3.2] | 0.518 | 6 | 26 | 1.2 [0.4–3.7] | 0.777 | |
| WUR pain site (VRS-ratio) | ≤ 2.5 | 35 | 24 | ref | 12 | 48 | |||
| >2.5 | 15 | 17 | 0.6 [0.3–1.4] | 0.380 | 5 | 27 | 0.7 [0.2–2.3] | 0.780 | |
| VDT control site (x/8) | >7.7 | 49 | 12 | ref | |||||
| ≤ 7.7 | 26 | 6 | 1.1 [0.4–3.2] | 1.000 | |||||
| VDT pain site (x/8) | >4.3 | 52 | 13 | ref | |||||
| ≤ 4.3 | 23 | 5 | 1.2 [0.4–3.6] | 1.000 | |||||
| WUR control site (VRS-ratio) | ≤ 2.5 | 48 | 13 | ref | |||||
| >2.5 | 26 | 5 | 1.4 [0.5–4.4] | 0.782 | |||||
| WUR pain site (VRS-ratio) | ≤ 2.5 | 47 | 11 | ref | |||||
| >2.5 | 24 | 7 | 0.8 [0.3–2.3] | 0.783 | |||||
Resp30/50, Acupuncture responders defined according to a reduction in pain intensity after the first acupuncture treatment of at least 30 or 50%, respectively; VDT, vibration detection threshold; x/8, score out of eight on the Rydel-Seiffer tuning fork; WUR, wind-up ratio; VRS-ratio, ratio of the pain intensities evoked by one and by ten pin-prick stimuli of 256 mN as evaluated by the verbal rating scale (0–100); CS, control site; PS, pain site; OR, odds ratio; 95% CI, 95% confidence interval;
statistically significant at an α-level of 5% according to Fisher test.
Crude associations between acupuncture effects and patient characteristics.
| Gender | Male | 3 | 11 | ref | 1 | 13 | ref | ||
| Female | 35 | 45 | 2.9 [0.7–11.0] | 0.147 | 24 | 56 | 5.6 [0.7–45.0] | 0.103 | |
| Chronicity MPSS | 1 | 0 | 5 | ref | 0 | 5 | ref | ||
| 2 | 14 | 20 | - | 0.139 | 7 | 27 | - | 0.563 | |
| 3 | 24 | 31 | - | 0.077 | 18 | 37 | - | 0.310 | |
| Surgery | No | 28 | 39 | ref | 17 | 50 | ref | ||
| Yes | 10 | 17 | 0.8 [0.3–2.1] | 0.817 | 8 | 19 | 1.2 [0.5–3.3] | 0.797 | |
| Use of analgesics | No | 2 | 10 | ref | 1 | 11 | |||
| Yes | 36 | 46 | 3.9 [0.8–19.0] | 0.114 | 24 | 58 | 4.6 [0.6–37.2] | 0.172 | |
| Pain duration [m] | mdn (IQR) | 48 (16–166) | 116 (26–219) | 0,119 | 53 (14–145) | 82 (24–218) | 0,176 | ||
| Age [a] | mdn (IQR) | 53 (46–59) | 49 (42–51) | 0.005 | 55 (48–61) | 49 (42–52) | 0.006 | ||
| Gender | Male | 5 | 12 | ref | 1 | 16 | ref | ||
| Female | 32 | 47 | 1.6 [0.5–5.1] | 0.584 | 23 | 56 | 6.6 [0.8–52.5] | 0.062 | |
| Chronicity MPSS | 1 | 2 | 5 | ref | 1 | 6 | ref | ||
| 2 | 12 | 23 | 1.3 [0.2–7.8] | 1.000 | 10 | 25 | 2.4 [0.3–22.6] | 0.654 | |
| 3 | 23 | 31 | 1.9 [0.3–10.4] | 0.690 | 13 | 41 | 1.9 [0.2–17.3] | 1.000 | |
| Surgery | No | 25 | 42 | ref | 16 | 51 | ref | ||
| Yes | 12 | 17 | 1.2 [0.5–2.9] | 0.820 | 8 | 21 | 1.2 [0.5–3.3] | 0.798 | |
| Use of analgesics | No | 4 | 11 | ref | 0 | 15 | ref | ||
| Yes | 33 | 48 | 1.9 [0.6–6.5] | 0.393 | 24 | 57 | - | 0.019 | |
| Pain duration [m] | mdn (IQR) | 85 (21–217) | 49 (21–166) | 0.372 | 65 (17–219) | 66 (21–182) | 0.889 | ||
| Age [a] | mdn (IQR) | 51 (46–59) | 50 (42–52) | 0.063 | 55 (47–60) | 50 (41–52) | 0.010 | ||
| Gender | Male | 10 | 7 | ref | 2 | 15 | ref | ||
| Female | 42 | 36 | 0.8 [0.3–2.4] | 0.792 | 15 | 63 | 1.8 [0.4–8.7] | 0.729 | |
| Chronicity MPSS | 1 | 4 | 3 | ref | 2 | 5 | ref | ||
| 2 | 15 | 19 | 0.6 [0.1–3.1] | 0.685 | 3 | 31 | 0.2 [0.0–1.8] | 0.196 | |
| 3 | 33 | 21 | 1.2 [0.2–5.8] | 1.000 | 12 | 42 | 0.7 [0.1–4.2] | 0.655 | |
| Surgery | No | 37 | 29 | ref | 13 | 53 | ref | ||
| Yes | 15 | 14 | 0.8 [0.3–2.0] | 0.823 | 4 | 25 | 0.7 [0.2–2.2] | 0.573 | |
| Use of analgesics | No | 8 | 7 | ref | 3 | 12 | ref | ||
| Yes | 44 | 36 | 1.1 [0.4–3.2] | 1.000 | 14 | 66 | 0.8 [0.2–3.4] | 0.728 | |
| Pain duration [m] | mdn (IQR) | 87 (18–229) | 49 (21–166) | 0.267 | 123 (15–272) | 63 (21–173) | 0.344 | ||
| Age [a] | mdn (IQR) | 50 (43–55) | 51 (43–57) | 0.837 | 49 (45–57) | 51 (43–56) | 0.973 | ||
| Gender | Male | 12 | 5 | ref | |||||
| Female | 63 | 13 | 2.0 [0.6–6.7] | 0.308 | |||||
| Chronicity MPSS | 1 | 3 | 4 | ref | |||||
| 2 | 29 | 5 | 7.7 [1.3–45.5] | 0.031 | |||||
| 3 | 43 | 9 | 6.4 [1.2–33.5] | 0.036 | |||||
| Surgery | No | 53 | 12 | ref | |||||
| Yes | 22 | 6 | 0.8 [0.3–2.5] | 0.778 | |||||
| Use of analgesics | No | 10 | 5 | ref | |||||
| Yes | 65 | 13 | 2.5 [0.7–8.5] | 0.158 | |||||
| Pain duration [m] | mdn (IQR) | 66 (21–182) | 19 (59–202) | 0.911 | |||||
| Age [a] | mdn (IQR) | 50 (41–52) | 49 (34–54) | 0.549 | |||||
Resp30/50, Acupuncture responders defined according to a reduction in pain intensity after the first acupuncture treatment of at least 30 or 50%, respectively; MPSS, Mainz Pain Staging System; m, months; a, years; ref, reference category; mdn, median; IQR, interquartile range; OR, odds ratio; 95% CI, 95% confidence interval;
statistically significant at an α-level of 5% according to Fisher test for dichotomous variables and according to Mann-Whitney-U test for continuous variables.
Logistic regression models of age-adjusted associations between immediate analgesic acupuncture effects and high TS.
| WUR control site | OR | 4.3 | 3.8 | 5.5 | WUR pain site | OR | 3.2 |
| [95%-KI] | [1.6–11.8] | [1.4–10.2] | [1.7–17.1] | [1.2–8.9] | |||
| 0.005 | 0.007 | 0.003 | 0.024 | ||||
| Age [a] | OR | 1.08 | 1.06 | 1.11 | Age [a] | OR | 1.07 |
| [95%-KI] | [1.0–1.1] | [1.0–1.1] | [1.0–1.2] | [95%-KI] | [1.0–1.1] | ||
| 0.004 | 0.014 | 0.002 | 0.026 | ||||
| Constant | OR | 0.01 | 0.02 | 0.00 | Constant | OR | 0.01 |
| 0.001 | 0.003 | <0.001 | 0.002 | ||||
| Omnibus test | 0.001 | 0.003 | <0.001 | Omnibus test | 0.002 | ||
| H-L test | 0.407 | 0.311 | 0.169 | H-L test | 0.076 | ||
| Nagelkerkes R2 | 0.199 | 0.157 | 0.251 | Nagelkerkes R2 | 0.183 | ||
| VIF | 1.056 | 1.056 | 1.056 | VIF | 1.034 | ||
| Correctly classified | Yes | 55.3 | 36.1 | 26.1 | Correctly classified | Yes | 13.0 |
Resp30, Acupuncture responders defined according to a reduction in pain intensity after the first acupuncture treatment of at least 30%; WUR, wind-up ratio; VRS-ratio, ratio of the pain intensities evoked by one and by ten pin-prick stimuli of 256 mN as evaluated by the verbal rating scale (0–100); CS, control site; PS, pain site; a, years; OR, odds ratio; 95% CI, 95% confidence interval; H-L test, Hosmer-Lemeshow test; VIF, variation inflation factor;
statistically significant at an α-level of 5%.
Figure 3Cumulative response functions in patients with high and low TS at the control site by age-group. Reduction in pain intensity was evaluated by the verbal rating scale (0–100) before and after the first acupuncture treatment. The age cut-off of 53 years was estimated by a receiver operating characteristic analysis. TS, temporal summation of pain; WUR, wind-up ratio [ratio of the pain intensities evoked by one and by ten pin-prick stimuli of 256 mN as evaluated by the verbal rating scale (0–100)]; CS, control site; a, years.